Gilead Sciences | GILD - Market Capitalization

Stock Price
141.02
Daily Change
1.65 1.18%
Monthly
-6.01%
Yearly
26.03%
Q2 Forecast
130.22

Gilead Sciences reported $174.41B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
ALKERMES USD 4.62B 333M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.42B 1.02B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
United Therapeutics USD 20.98B 2.02B Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025